öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÌÆΰ·½
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º265

ËùÊôԺУ£ºÖйúÒ©¿Æ´óѧ
ËùÊôԺϵ£ºÀíѧԺ
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Îﻯѧ
Ñо¿ÁìÓò£º £¨Ò»£©»¯Ñ§Ò©ÎïµÄÉè¼ÆÓëºÏ³É¡££¨¶þ£©ÓлúºÏ³É»¯Ñ§
Ñо¿ÁìÓò£º £¨Ò»£©»¯Ñ§Ò©ÎïµÄÉè¼ÆÓëºÏ³É¡££¨¶þ£©ÓлúºÏ³É»¯Ñ§ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºtangwf126@126.com


¸öÈ˼òÊö :
ÏÖÈÎÖйúÒ©¿Æ´óѧÀíѧԺ¸±Ôº³¤¡£

¿ÆÑй¤×÷ :
Ö÷³ÖºÍ²ÎÓëÁ˹ú¼Ò×ÔÈ»¿Æѧ»ù½ð(**)£¬½­ËÕÊ¡×ÔÈ»¿Æѧ»ù½ð£¬ÖÐÑë¸ßУ»ù±¾¿ÆÑÐÒµÎñ·ÑרÏî»ù½ðÖصã»ù´¡Ñо¿µÈ¶àÏî¿ÆÑÐÏîÄ¿¡£ÔÚ½ÌοÎÌâ×éÖ¸µ¼ºÍÅàÑøÑо¿Éú£¬±¾¿ÎÌâ×éÄ¿Ç°³Ðµ£¶àÏî¹ú¼ÒºÍÊ¡×ÔÈ»»ù½ðÏîÄ¿£¬²¢Óë¶à¼ÒÒ©Æó½øÐÐÐÂÒ©ÁªºÏ¿ª·¢£¬¿ÆÑо­·Ñ³ä×ã¡£2015Äê¿ÎÌâ×é·¢ÏÖµÄ1.1À࿹Ö×ÁöÐÂÒ©ÁÙ´²Ç°»¯ºÏÎïÒÔ5000ÍòÈËÃñ±ÒתÈøøÉÏÊй«Ë¾ÉϺ£¸´ÐÇÒ½Ò©¡£Ö÷±àºÍ²Î±àѧÊõÖø×÷ºÍ½Ì²Ä8±¾£¬ÉêÇëÖйú·¢Ã÷רÀû5ÏÆäÖÐ2ÏîÒÑ»ñÊÚȨ¡£ÔÚEur. J. Med. Chem.¡¢J. Org. Chem.¡¢Adv. Synth. Catal.µÈ¹ú¼ÊѧÊõÆÚ¿¯·¢±íSCIÂÛÎÄ20¶àƪ¡£
½üÄê·¢±íµÄÖ÷ÒªÂÛÎÄ£º
[1]Lu Wang, Gaoyuan Zhu, Qing Zhang, Chunqi Duan, Yanmin Zhang, Zhimin Zhang, Yujun Zhou, Tao LU*, Weifang Tang*. Rational design, synthesis, and biological evaluation of Pan-Raf inhibitors to overcome resistance. Organic & Biomolecular Chemistry. 2017,15,3455-3465[2] Lu Wang, Qing Zhang, Gaoyuan Zhu, Zhimin Zhang, Li Zhang, Tianxiao Mao, Xiang Zhou, Yadong Chen, Tao LU*, Weifang Tang*. Design, synthesis and evaluation of derivatives based on pyrimidies scaffold as potent Pan-Raf inhibitors to overcome resistance. Eur. J. Med. Chem. 2107,130,86-106[3] Jing Cao, Shuding Dong, Delu Jiang, Peiyu Zhu, Han Zhang, Rui Li, Xuanyu Wang, Weifang Tang* and Ding Du*. ¦Â-Functionalization of Indolin-2-one-Derived Aliphatic Acids for the Divergent Synhesis of Spirooxindole ¦Ã-Butyrolactones. J. Org. Chem. 2017.82.4186-4193[4] Yong Zhu, Ting Ran, Xin Chen, Jiaqi Niu, Shuang Zhao, Tao Lu and Weifang Tang*. Synthesis and Biological Evaluation of 1-(2-Aminophenyl)-3-arylurea Derivatives as Potential EphA2 and HDAC Dual Inhibitors. Chem. Pharm. Bull. 2016,64,1136-1141[5] Weifang Tang and Ding Du. Access to spiro and fused indole derivatives from ¦Á,¦Â-unsaturated aldehydes enabled by N-heterocyclic carbene catalysis. Chem. Rec. 2016,16,1489-1500[6]Yu Jiao, Fei Huang, Pengfei Xu, Yanmin Zhang, Shanfyan, Danfeng Zhang,Tao Lu and Weifang Tang. Discovery and Optimization of 1-(4-chloro-3-(trifluoromethyl) phenyl)-3-(2-amino)pyridine- 3-yl)ureas as Novel KDR Kinase Inhibitors. Med. Chem. 2016,12,328-337[7]Yu Jiao, Bo-Tao, Yanmin Zhang, Jianbing Wu, Xiaolin Lu, Ying Zheng, Weifang Tang*, Xiang Zhou*. Design, synthesis and evaluation of novel 2-(1H-imidazol- 2-yl)pyridine derivatives as potential BRAF inhibitors and anti-tumor agents. Eur. J. Med. Chem. 2105,90,170-183[8] Weimin Yang, Yadong Chen, Xiang Zhou, Yazhou Gu, Wenqi Qian, Fan Zhang, Tao Lu*, Weifang Tang* . Design, sythesis and biological evalution of bis-aryl ureas and amides based on 2-amino-3 purinypyridine scaffold as DFG-out B-Raf kinase inhibitors. Eur. J. Med. Chem. 2015,89,581-596[9] Weimin Yang, Yadong Chen, Yanmin Zhang, Sanzhi Tang ,Hongli Chen, Weifang Tang* and Tao Lu*. Design, Sythesis and Antitumor Activities of Bis- arylureas and Bis-arylamines Based on 1H-benzo[d]imidazole Woiety as Novel B-RafV600E/ VEGFR2 Dual Inhibitors. Lett Drug Des Discov. 2014,11, 1079- 1089[10] Zeng Wu, Ming Yan, Shi-He Hu, Zhi-Cheng Yu, Yong Zhu, Ya-Dong Chen, Hai-Chun Liu, Yan-Min Zhang, Si-Hui Yao, Wei-Fang Tang*, Tao Lu*. Design, sythesis and biological evalution of indole derivatives as novel inhibitors taegeting B-Raf kinase. Chinese Chemlett. 2014,25,351-354[11]. Yingyan, Weifang Tang, Yu Zhang, Ding Du, and Taolu. N-Heterocyclic Carbene-Catalyzed Annulations of Enals and Ynals with Indolin-3-ones: Synthesis of 3,4-Dihydropyrano[3,2-b] indol-2-ones. Adv. Synth. Catal. 355:321-326, 2013.[12] Yong Zhu, Xin Chen, Zeng Wu, Yixuan Zheng, Yadong Chen, Weifang Tang*, Tao Lu*. Synthesis and Antitumor Activity of Novel Diaryl Ether Hydroxamic Acids Derivatives as Potential HDAC Inhibitors. Arch Pharm Res. 2012,35(10): 1723-1732[13].Botao Xin, Weifang Tang, Yue Wang, Guowu Lin, Haichun Liu, Yu Jiao, Yong Zhu, Haoliang Yuan, Yadong Chen, Yao Lu*. Dessign, sythesis and biological evalution of ¦Â-carboline derivatives as novel inhibitors targeting B-Raf kinase. Bioorg. Med. Chem. Lett. 22(4): 4783-4786, 2012.